News

U.S. Army Commits to Javelin's Lightweight Command Launch Unit

U.S. Army Commits to Javelin's Lightweight Command Launch Unit

U.S. Army Commits to Javelin's Lightweight Command Launch Unit

The U.S. Army has made a significant decision regarding the future of its defense capabilities by awarding the Javelin Joint Venture (JJV) two production contracts worth $267 million for the Lightweight Command Launch Units (LWCLU). This move marks a strategic step in enhancing both U.S. military capabilities and support for allied nations.

Commitment to Defense and Innovation

With the recent contracts for LWCLU, the JJV is poised to introduce these advanced systems not only to the U.S. Army but also to the U.S. Marine Corps and various international partners. Andy Amaro, the president of JJV and director of the Javelin program at Raytheon, emphasized that achieving full-rate production for the LWCLU is a considerable milestone, aiming to reduce risks, optimize costs, and ultimately speed up delivery times.

Advantages of the LWCLU

The Lightweight Command Launch Unit represents a significant leap forward in military technology. It is 30% smaller and 25% lighter than its predecessor, while simultaneously doubling target detection and recognition capabilities. This enhanced functionality maximizes surveillance and allows soldiers to engage targets effectively both day and night. The LWCLU is designed to be adaptable, working seamlessly with all current, past, and future Javelin variants.

Technological Advancement

According to Dave Pantano, JJV vice president and Javelin program director at Lockheed Martin, the LWCLU offers cutting-edge deterrence solutions needed in critical situations, utilizing efficient fire-and-forget technology. This full-rate production will enable the JJV to supply enhanced capabilities that meet the evolving requirements of global defense systems.

Manufacturing and Future Production

Javelin systems are developed collaboratively by the JJV, which includes Raytheon RTX and Lockheed Martin, both critical players in the defense technology sector. The JJV has a remarkable production record, with over 50,000 Javelin missiles and more than 12,000 reusable Command Launch Units produced to date. The contracts will see production activities concentrated in Tucson, Arizona, with completion anticipated by 2026 and 2028.

Raytheon and RTX: Leaders in Defense

As a company, Raytheon RTX plays a pivotal role in providing advanced defense solutions to the U.S. government and allied nations, ensuring their security and sovereignty. With over a century of experience, Raytheon is at the forefront of technology development in areas such as missile defense, advanced sensors, and integrated air defense systems.

The Scale of RTX

RTX, with more than 185,000 employees worldwide, is dedicated to pushing technological boundaries. With a portfolio that includes Collins Aerospace, Pratt & Whitney, and Raytheon, the company is integral to advancing defense systems and delivering innovative solutions that address critical global challenges.

Contact for Inquiries

For media inquiries or to arrange interviews, interested parties can contact corporate communications at corporatepr@rtx.com.

Frequently Asked Questions

What is the Lightweight Command Launch Unit?

The LWCLU is an advanced military system designed for launching Javelin missiles with enhanced mobility and efficiency, measuring 30% smaller and 25% lighter than its predecessor.

Who awarded the LWCLU contracts?

The U.S. Army awarded the contracts to the Javelin Joint Venture, comprising Raytheon and Lockheed Martin.

What are the benefits of the LWCLU?

The LWCLU enhances target detection, recognition, and engagement capabilities, providing soldiers with greater operational flexibility.

Where will the production of the Javelin take place?

Production work for the LWCLU will primarily occur in Tucson, Arizona.

How many Javelin missiles has the JJV produced so far?

The JJV has produced more than 50,000 Javelin missiles and over 12,000 Command Launch Units to date.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 5

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Micro Irrigation Systems: The Future of Sustainable Farming

Updated Category News Views 184

Micro Irrigation Systems: Transforming Global Agriculture The micro irrigation systems market is poised for remarkable growth, expected to expand significantly due to the increasing demand for sustainable agricultural practices. These systems are projected to elevate market valuation from USD 10.9 billion to USD 27.4 billion over the next decade, exhibiting a strong CAGR...

Continue Reading
Empowering Communities: Diaspora Groceries Supplier Summit Launch

Updated Category News Views 276

Empowering Communities: Diaspora Groceries Supplier Summit Launch Diaspora Groceries is thrilled to announce its inaugural Diaspora Diversity Supplier Summit, in partnership with its newly established nonprofit arm, Diaspora Groceries Cares. Taking place over two transformative days, the summit invites food suppliers, farmers, and advocates to gather for insightful...

Continue Reading
EMP Metals Unveils Enhanced Resource Estimate for Lithium Projects

Updated Category News Views 95

EMP Metals Reports Updated Resource Estimate EMP Metals Corp. (CSE: EMPS, OTCQB: EMPPF) is thrilled to share an updated Technical Report detailing the resource estimates for its Viewfield and Mansur lithium brine projects. This comprehensive report showcases a remarkable increase in the total resource, significantly boosting both the indicated and inferred lithium...

Continue Reading
Exploring the Impact of Google Cloud in Enterprise Solutions

Updated Category News Views 264

ISG Evaluates Google Cloud Partner Ecosystem Information Services Group (ISG) (Nasdaq: III), a prominent global technology research and advisory firm, is embarking on an in-depth research study that will gauge the effectiveness of service providers in supporting enterprises using the Google Cloud Platform (GCP) for artificial intelligence (AI) and various other workloads....

Continue Reading
HiRO Joins Forces with CHA University for Future of Health

Updated Category News Views 294

HiRO Collaborates with CHA University Bundang Medical Center Harvest Integrated Research Organization (HiRO), a distinguished global clinical research organization (CRO), has recently entered into a strategic partnership with CHA University Bundang Medical Center (CBMC), a highly respected medical institution in South Korea. This collaboration promises to strengthen the...

Continue Reading